China’s healthcare expenditures are increasing, with the imbalance between social health insurance revenues and expenditures continuing to intensify. This article investigates the transition from the currently mainstream fee-for-service model to the diagnosis-related group (DRG) payment model, the history of DRG in foreign markets, and the potential challenges to having a DRG payment model in China’s system.
Download the PDF